Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2021-04-02FDA Approved: RAMIPRIL — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application for Ramipril from Rising Pharma Holdings, Inc., indicating an updated approval under the ANDA.
-
CLINICAL_TRIALS trial_result · 2021-04-01Clinical Trial Update: Triple Therapy Prevention of Recurrent Intracerebral Disease EveNts Trial (TRIDENT) Cognitive Sub-Study [Phase 3]
A Phase 3 trial (TRIDENT) evaluating triple therapy for prevention of recurrent intracerebral events has been terminated; cognitive sub-stud…
-
FDA approval · 2021-03-30FDA Approved: METOLAZONE — Original Application (Unichem Pharmaceuticals (USA), Inc.)
FDA approves the original ANDA for Metolazone from Unichem Pharmaceuticals (USA), Inc., establishing its generic status.
-
FDA approval · 2021-03-30FDA Approved: METOLAZONE — Original Application (Method Pharmaceuticals, LLC)
FDA approved METOLAZONE under an original ANDA from Method Pharmaceuticals, LLC (generic approval).
-
FDA approval · 2021-03-22FDA Approved: DILTIAZEM HYDROCHLORIDE — Original Application (GLENMARK PHARMACEUTICALS INC., USA)
FDA approves Glenmark's diltiazem hydrochloride as an original ANDA; the product is a generic calcium channel blocker indicated for hyperten…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-03-10Clinical Trial Update: Effect of Berberine Hydrochloride on Blood Pressure and Vascular Endothelial Function in Patients With Hypertension [Phase 4]
Phase 4 clinical trial investigating the effect of berberine hydrochloride on blood pressure and vascular endothelial function in hypertensi…
-
CLINICAL_TRIALS trial_result · 2021-03-08Clinical Trial Update: Anti-hypertensive Medication Dosing Regimen in Effective Blood Pressure Control [Phase 4]
Phase 4 trial update on anti-hypertensive dosing regimen for effective blood pressure control.
-
CLINICAL_TRIALS trial_result · 2021-03-08Clinical Trial Update: Digital Home Blood Pressure Monitoring in Type B Aortic Dissection Patients [NA]
Clinical trial update for digital home blood pressure monitoring in patients with aortic dissection and hypertension; study terminated with …
-
FDA approval · 2021-03-04FDA Approved: LISINOPRIL — Original Application (Chartwell RX, LLC)
FDA approves Chartwell RX, LLC’s original application for lisinopril, a generic ACE inhibitor. Lisinopril is used to treat hypertension, con…
-
FDA approval · 2021-03-03FDA Approved: GUANFACINE HYDROCHLORIDE — Original Application (Unichem Pharmaceuticals (USA), Inc.)
FDA approved a generic formulation of guanfacine hydrochloride under an Original Application (ANDA 214689) for Unichem Pharmaceuticals (USA)…
-
FDA approval · 2021-03-02FDA Approved: BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for the fixed-dose combination of bisoprolol fumarate and hydrochlorothiazide (Teva). This appro…
-
FDA approval · 2021-03-02FDA Approved: VERAPAMIL HYDROCHLORIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for Verapamil Hydrochloride by Mylan Pharmaceuticals, signaling approval of an updated or additional…
-
FDA approval · 2021-02-26FDA Approved: SPIRONOLACTONE — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for spironolactone from Mylan Pharmaceuticals, resulting in changes to the product labeling as p…
-
FDA approval · 2021-02-26FDA Approved: SPIRONOLACTONE — Supplemental Application (Accord Healthcare, Inc.)
FDA approved a supplemental application for Accord Healthcare's generic spironolactone. This action confirms approval of modifications under…
-
FDA approval · 2021-02-26FDA Approved: SPIRONOLACTONE — Supplemental Application (Oxford Pharmaceuticals, LLC)
The FDA approved a supplemental application for spironolactone from Oxford Pharmaceuticals, LLC, under the existing ANDA.
-
CLINICAL_TRIALS withdrawal · 2021-02-24Clinical Trial Update: Fixed-dose Combination of Valsartan + Rosuvastatin Versus Their Isolated Components for Hypertension and Dyslipidemia. [Phase 3]
Phase 3 trial of a fixed-dose combination of valsartan and rosuvastatin was withdrawn.
-
CLINICAL_TRIALS trial_result · 2021-02-24Clinical Trial Update: Reducing Disparities in the Treatment of Hypertension Using the OWL mHealth Tool [NA]
A completed clinical trial evaluating the OWL mHealth tool to reduce disparities in hypertension treatment.
-
FDA label_change · 2021-02-22FDA Approved: EXFORGE HCT — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA supplemental application for EXFORGE HCT, a fixed-dose combination of amlodipine, valsartan, and hydrochlorothiazide, submitted by Novar…
-
CLINICAL_TRIALS trial_result · 2021-02-21Clinical Trial Update: CAndesartan vs LIsinopril Effects on the BRain [Phase 2]
Phase 2 trial comparing candesartan to lisinopril in hypertension with mild cognitive impairment has completed with results posted.
-
FDA approval · 2021-02-19FDA Approved: SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE — Supplemental Application (Prasco Laboratories)
The FDA approved a supplemental application for Spironolactone and Hydrochlorothiazide by Prasco Laboratories, authorizing its marketing as …
-
CLINICAL_TRIALS trial_result · 2021-02-17Clinical Trial Update: Effect of Amlodipine Versus Bisoprolol on Hypertensive Patients With End-stage Renal Disease on Maintenance Hemodialysis. [Phase 4]
A Phase 4 trial comparing amlodipine to bisoprolol in hypertensive patients with end-stage renal disease on maintenance hemodialysis has com…
-
FDA approval · 2021-02-12FDA Approved: METOPROLOL SUCCINATE — Original Application (Epic Pharma, LLC)
FDA approves the original application for metoprolol succinate as a generic extended-release beta-blocker indicated for hypertension and hea…
-
CLINICAL_TRIALS trial_result · 2021-02-11Clinical Trial Update: The Effect of Grape Seed Extract on Blood Pressure in People With Pre-Hypertension [NA]
Clinical trial evaluating grape seed extract for blood pressure in pre-hypertension has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2021-02-05Clinical Trial Update: Anti Inflammatory Treatment of Hypertension [Phase 2, Phase 3]
Phase 2/3 trial update on an anti-inflammatory treatment for hypertension, completed.
-
CLINICAL_TRIALS withdrawal · 2021-02-04Clinical Trial Update: Treating Nocturnal Hypertension and Nocturia in African American Men [Phase 4]
Phase 4 clinical trial investigating treatment of nocturnal hypertension and nocturia in African American men has been withdrawn.